Hepatic neuromodulation to treat fatty liver conditions
US9011422B2 · kind B2 · utility
11Cited by
89References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2014 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Sep 25, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N7/022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to some embodiments, a method of treating conditions affecting a liver of a subject is provided. The method may include delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.